You are here


The Natural Experiments for Translation in Diabetes (NEXT-D) Study examines how the Affordable Care Act expansion of Medicaid will affect diabetes diagnosis, treatment, and outcomes among the newly enrolled. We will compare differences that arise between some states expanding Medicaid and others choosing not to do so. Data will be combined with detailed, longitudinal electronic health record (EHR) data for a large population of 9 million in four expansion and five non-expansion states.

This cooperative agreement is jointly funded by the Centers for Disease Control and Prevention (CDC) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CDC Funding Opportunity Announcement (FOA) Number: RFA-DP10-002, entitled Natural Experiments and Effectiveness Studies to Identify the Best Policy and System Level Practices to Prevent Diabetes and Its Complications. 

The NEXT-D project utilizes the CAPriCORN data repository to create the study population. The study population's individual addresses will then be geocoded to create the control group for analysis. With the connections to CAPriCORN, CHiP Director Abel Kho is co-principal investigator with Bernard Black, also a Northwestern University faculty member.


Other Information:

  • Principal Investigators:
  • Co-Investigators:
  • Participating GPC Sites:
    • University of Kansas Medical Center
    • Indiana University
    • Medical College of Wisconsin
    • University of Iowa
    • University of Minnesota
    • University of Missouri
    • University of Nebraska Medical Center
    • University of Texas Southwestern Medical Center
  • Status: Funded
  • Project Dates: 9/30/15 - 9/29/20


  Back to list of Initiatives